Breaking News


Study finds benefit of continued alefacept-methotrexate treatment in psoriatic arthritis


The addition of a single course of alefacept to methotrexate therapy was effective in treating psoriatic arthritis in a clinical study, and an open-label extension has found further treatment with alefacept to extend the benefit in some patients. In the open-label extension, patients receiving stable doses of methotrexate were given an additional 12 weekly intramuscular injections of alefacept and were observed for another 12 weeks. At the end of the extension, an ACR20 response was achieved by 86 of 160 patients (54%); responders including 28 patients who had previously been given placebo plus methotrexate and 58 patients who had previously been given alefacept plus methotrexate. A second course did not increase the ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list